Comparing safety profiles of piperacillin-tazobactam and cefepime could help in choosing the safer empirical therapy for emergency department patients with suspected sepsis, suggests a new JAMA study.
Many "long-haulers" experience extended neurologic symptoms, such as brain fog, but new research suggests that these may differ based on disease severity.
The shocking information revealed in this study emerges just days before school districts across the US reopen their doors to tens of millions of students, teachers, and other school staff for fully in-person learning.